Rollover Study to Provide Continued Treatment for Participants With B-Cell Malignancies Previously Enrolled in Studies of Parsaclisib (INCB050465)
Clinical trial NCT04509700 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04509700
- Sponsor
- Incyte Corporation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-03
- Primary completion
- 2026-11-05
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.